Company Filing History:
Years Active: 2018
Title: Juhyeon Kim: Innovator in Histone Methyltransferase Inhibition
Introduction
Juhyeon Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biochemistry, particularly in the area of histone methyltransferases. His innovative work has led to the development of a unique quinoline derivative that has potential therapeutic applications.
Latest Patents
Juhyeon Kim holds a patent for "Quinoline derivatives for inhibiting histone methyltransferases and use thereof." This patent describes a quinoline derivative that inhibits the activity of histone methyltransferases, specifically ESET/SETDB1, which targets the histone molecule H3K9. The invention also includes pharmaceutically acceptable salts of the derivative and outlines its potential uses in medical applications.
Career Highlights
Juhyeon Kim is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the field of biochemistry. His work has garnered attention for its innovative approach to addressing complex biological processes.
Collaborations
Juhyeon Kim collaborates with esteemed colleagues, including Hyunah Choo and Sun-Joon Min, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the scientific community.
Conclusion
Juhyeon Kim's contributions to the field of histone methyltransferase inhibition exemplify the importance of innovation in biochemistry. His patent and ongoing research hold promise for future therapeutic advancements.